Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Overuse of Antidepressant in Patients With Alzheimer Disease and Associated Disorders : An Observational Study
Authors not listed
Assistance Publique - Hôpitaux de Paris · 2015
Abstract
Near 40% of French people aged 65 years and over and suffering from Alzheimer disease and associated disorders (ADAD) are exposed to antidepressants (AD) versus 13% of those without ADAD. If depression and anxiety disorders are comorbidities frequently associated with dementia, such level of AD exposure suggests an overuse of AD in this population.
Hypothesis: Overuse of AD is frequent in patients with ADAD. It is possible to assess overuse associated with off label prescriptions (no validated indication and excess in prescription duration) Main objective: to assess the prevalence of AD overuse associated with off label prescriptions (no validated indication and excess in prescription duration) in patients aged 70 years and over with ADAD.
Secondary objectives:
1. To assess the prevalence of AD prescribed for a non validated indication
2. To assess the prevalence of AD prescribed with excess in prescription duration
3. To assess the prevalence of psychotropic coprescription and notably the prevalence of the neurologic iatrogenic alerts as defined by the French National Authority for Health
4. To assess factors associated to AD overuse Method: A transversal monocentric study in the geriatric day Bretonneau unit will be performed. Study will be proposed to all eligible patients (with non-opposition of the patient or of his legal representative to the collection of his personal data). Included people will have no supplementary clinical or complementary investigations. The geriatrician in charge will have to systematically collect the indication and the history of the AD treatment. At the end of the evaluation performed in the geriatric day unit, the geriatrician will have to conclude to the AD overuse or not associated with off label prescription. Doubtful case will be examined by a validation committee.
Eligibility criteria: Patient consulting in geriatric day hospital with age ≥70 years and dementia according to DSMIV criteria, whatever its level and antidepressant prescription.
Sample size Considering that 40% of people suffering from ADAD are prescribed antidepressant (data from French Health Insurance), the number of eligible patients consulting in the geriatric day swill be 65 in 6 months. If 10% of them are opposed to the collection of their personal data and if the overuse of AD is near 50%, precision of the result will be 12.8% (95%CI bilateral).
Duration of inclusion: 6 months Duration of patient's participation: one day
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-26 MST
Cite this
APA
Anonymous. (2015). Overuse of Antidepressant in Patients With Alzheimer Disease and Associated Disorders : An Observational Study. <em>Assistance Publique - Hôpitaux de Paris</em>. https://clinicaltrials.gov/study/NCT02529436
Vancouver
Anonymous. Overuse of Antidepressant in Patients With Alzheimer Disease and Associated Disorders : An Observational Study. Assistance Publique - Hôpitaux de Paris. 2015.
BibTeX
@misc{anon2015Overus,
title = {Overuse of Antidepressant in Patients With Alzheimer Disease and Associated Disorders : An Observational Study},
author = {Anonymous},
journal = {Assistance Publique - Hôpitaux de Paris},
year = {2015},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of Cachexia Sarcopenia and Muscle 2022
Open access · CC-BY
Association of shorter leucocyte telomere length with risk of frailty
Assiut University 2026
Open access · US-GOV
Frailty Syndrome and Its Associated Factors Among Elderly Patients Attending Assiut University Hospitals
International Journal of Environmental Research and Public Health 2023
Open access · CC-BY
Impact of Physical Activity on Anxiety, Depression, Stress and Quality of Life of the Older People in Brazil
Alzheimer s Research & Therapy 2019
Open access · CC-BY
Effects of spermidine supplementation on cognition and biomarkers in older adults with subjective cognitive decline (SmartAge)—study protocol for a randomized controlled trial
Antonia Pierobon 2020
Open access · US-GOV
Cognitive Impairment, Frailty and Rehabilitative Outcome in Older Patients Affected by Cardiorespiratory Disease (DEC_FRAinRIAB)
Frontiers in Sports and Active Living 2025
Open access · CC-BY